Bastuji-Garin S - Search Results

1

Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.

Khosrotehrani K, Bastuji-Garin S, Riccardi VM, Birch P, Friedman JM, Wolkenstein P. Khosrotehrani K, et al. Am J Med Genet A. 2005 Jan 1;132A(1):49-53. doi: 10.1002/ajmg.a.30394. Am J Med Genet A. 2005. PMID: 15523617

2

A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome.

Wolkenstein P, Carrière V, Charue D, Bastuji-Garin S, Revuz J, Roujeau JC, Beaune P, Bagot M. Wolkenstein P, et al. Pharmacogenetics. 1995 Aug;5(4):255-8. doi: 10.1097/00008571-199508000-00011. Pharmacogenetics. 1995. PMID: 8528274 No abstract available.

3

High risk of death in elderly patients with extensive bullous pemphigoid.

Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. Roujeau JC, et al. Arch Dermatol. 1998 Apr;134(4):465-9. doi: 10.1001/archderm.134.4.465. Arch Dermatol. 1998. PMID: 9554299

4

Pulmonary embolism; lung scanning interpretation: about words.

Bastuji-Garin S, Schaeffer A, Wolkenstein P, Godeau B, Carville C, Durand-Zaleski I, Meignan M. Bastuji-Garin S, et al. Chest. 1998 Dec;114(6):1551-5. doi: 10.1378/chest.114.6.1551. Chest. 1998. PMID: 9872187

5

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.

Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. Bastuji-Garin S, et al. J Invest Dermatol. 2000 Aug;115(2):149-53. doi: 10.1046/j.1523-1747.2000.00061.x. J Invest Dermatol. 2000. PMID: 10951229 Free article.

6

Reliability of the histopathologic diagnosis of malignant melanoma in childhood.

Wechsler J, Bastuji-Garin S, Spatz A, Bailly C, Cribier B, Andrac-Meyer L, Vergier B, Fraitag S, Verola O, Wolkenstein P; French Cutaneous Cancerology Group. Wechsler J, et al. Arch Dermatol. 2002 May;138(5):625-8. doi: 10.1001/archderm.138.5.625. Arch Dermatol. 2002. PMID: 12020223

7

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

Guillamo JS, Créange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P; Réseau NF France. Guillamo JS, et al. Brain. 2003 Jan;126(Pt 1):152-60. doi: 10.1093/brain/awg016. Brain. 2003. PMID: 12477702

8

Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients.

Khosrotehrani K, Bastuji-Garin S, Zeller J, Revuz J, Wolkenstein P. Khosrotehrani K, et al. Arch Dermatol. 2003 Feb;139(2):187-91. doi: 10.1001/archderm.139.2.187. Arch Dermatol. 2003. PMID: 12588224

9

French people and skin diseases: results of a survey using a representative sample.

Wolkenstein P, Grob JJ, Bastuji-Garin S, Ruszczynski S, Roujeau JC, Revuz J; Société Française de Dermotologie. Wolkenstein P, et al. Arch Dermatol. 2003 Dec;139(12):1614-9; discussion 1619. doi: 10.1001/archderm.139.12.1614. Arch Dermatol. 2003. PMID: 14676080

10

Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.

Valeyrie-Allanore L, Ismaïli N, Bastuji-Garin S, Zeller J, Wechsler J, Revuz J, Wolkenstein P. Valeyrie-Allanore L, et al. Br J Dermatol. 2005 Jul;153(1):79-82. doi: 10.1111/j.1365-2133.2005.06558.x. Br J Dermatol. 2005. PMID: 16029330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters